Evaluating Renal Biomarkers in Diabetic Nephropathy: Significant Variations Across Groups

dc.contributor.author	Botirova Nigina Akram qizi
dc.date.accessioned	2026-01-01T10:19:12Z
dc.date.issued	2024-10-26
dc.description.abstract	Diabetic nephropathy (DN) is one of the most serious complications associated with diabetes mellitus (DM) and a leading cause of end-stage renal disease (ESRD) worldwide. DN is characterized by progressive kidney dysfunction, typically manifesting as albuminuria, glomerular hypertrophy, and a gradual decline in the glomerular filtration rate (GFR). Early detection and intervention are crucial to prevent the progression of DN to ESRD, making the study of renal biomarkers an essential aspect of understanding DN's pathophysiology and improving patient outcomes
dc.format	application/pdf
dc.identifier.uri	https://zienjournals.com/index.php/tjms/article/view/5620
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/59912
dc.language.iso	eng
dc.publisher	Zien Journals
dc.relation	https://zienjournals.com/index.php/tjms/article/view/5620/4593
dc.rights	https://creativecommons.org/licenses/by-nc/4.0
dc.source	Texas Journal of Medical Science; Vol. 37 (2024): TJMS; 24-26
dc.source	2770-2936
dc.subject	ESRD
dc.subject	improving
dc.subject	pathophysiology
dc.subject	outcomes
dc.title	Evaluating Renal Biomarkers in Diabetic Nephropathy: Significant Variations Across Groups
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: qizi_2024_evaluating_renal_biomarkers_in_diabetic.pdf
item.page.filesection.size: 167.83 KB
item.page.filesection.format: Adobe Portable Document Format